In Vitro Activities of Luliconazole, Lanoconazole, and Efinaconazole Compared With Those of Five Antifungal Drugs Against Melanized Fungi and Relatives

Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):

Share this content! On (X network) By

In Vitro Activities of Luliconazole, Lanoconazole, and Efinaconazole Compared With Those of Five Antifungal Drugs Against Melanized Fungi and Relatives Publisher Pubmed

Shokoohi GR¹ ; Badali H² ; Mirhendi H³ ; Ansari S⁴ ; Rezaeimatehkolaei A⁵ ; Ahmadi B⁶ ; Vaezi A^{2, 7} ; Alshahni MM⁸ ; Makimura K⁸

Show Affiliations

1. Department of Medical Parasitology and Mycology, School of Public Health, National Institute of Health Research, Tehran University of Medical Sciences, Tehran, Iran
2. Department of Medical Mycology and Parasitology, Invasive Fungi Research Center, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran
3. Department of Medical Parasitology and Mycology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
4. Department of Parasitology and Mycology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
5. Infectious and Tropical Diseases Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
6. Department of Microbiology and Parasitology, School of Para-Medicine, Bushehr University of Medical Sciences, Bushehr, Iran
7. Student Research Committee Center, Mazandaran University of Medical Sciences, Sari, Iran
8. Laboratory of Space and Environmental Medicine, Graduate School of Medicine, Teikyo University, Tokyo, Japan

Source: Antimicrobial Agents and Chemotherapy Published:2017

Abstract

The in vitro activities of novel azoles compared to those of five antifungal drugs against clinical (n 28) and environmental (n 102) isolates of black mold and melanized yeast were determined. Luliconazole and lanoconazole had the lowest geometric mean MICs, followed by efinaconazole, against tested isolates compared to the other drugs. Therefore, it appears that these new imidazole and triazole drugs are promising candidates for the treatment of infections due to melanized fungi and their relatives. Copyright © 2017 American Society for Microbiology. All Rights Reserved.

Related Docs

View other Related Docs

1. Antifungal Activity of a Novel Triazole, Efinaconazole and Nine Comparators Against 354 Molecularly Identified Aspergillus Isolates, Mycopathologia (2020)

2. In Vitro Antifungal Susceptibility Profile of Iranian Fusarium Isolates: Emphasising on the Potent Inhibitory Effect of Efinaconazole Compared to Other Drugs, Mycoses (2023)

3. Synthetic Approaches and Structural Diversity of Triazolylbutanols Derived From Voriconazole in the Antifungal Drug Development, European Journal of Medicinal Chemistry (2022)

4. Detection of Erg11 Point Mutations in Iranian Fluconazole-Resistant Candida Albicans Isolates, Current Medical Mycology (2019)

5. Synthesis and Antifungal Activity Evaluation of a Fluconazole Analog Derived From Dithiocarbamate, Journal of Mazandaran University of Medical Sciences (2024)

6. In-Vivo Efficiency of the Novel Azole Compounds (Attaf-1 and Attaf-2) Against Systemic Candidiasis in a Murine Model, Journal of Medical Mycology (2023)

7. Evaluation and Comparison of Antifungal Effect of Voriconazole With Nystatin on Candida Species Derived From Neoplastic Patients Undergoing Maxillofacial Radiotherapy, Dental Research Journal (2023)

8. Overview on the Infections Related to Rare Candida Species, Pathogens (2022)

Experts (# of related papers)

View all Related Experts

Rasoul Mohammadi (19)

Seyed Hossein Mirhendi Esfahani (10)

Other Related Docs

9. Synergistic Activity Between Echinophora Platyloba Dc Ethanolic Extract and Azole Drugs Against Clinical Isolates of Candida Albicans From Women Suffering Chronic Recurrent Vaginitis, Journal de Mycologie Medicale (2014)

10. In Vitro Antifungal Susceptibility Profile of Miltefosine Against a Collection of Azole and Echinocandins Resistant Fusarium Strains, Journal of Fungi (2022)

11. In Vitro Susceptibility Patterns of Clinically Important Trichophyton and Epidermophyton Species Against Nine Antifungal Drugs, Mycoses (2015)

12. Antifungal Activity of Anethum Graveolens Extract and Atrovastatin Against Candida Species Compared to Fluconazole, Journal of Isfahan Medical School (2015)

13. Species Identification and in Vitro Antifungal Susceptibility Testing of Aspergillus Section Nigri Strains Isolated From Otomycosis Patients, Journal de Mycologie Medicale (2018)

14. Isolation and Molecular Characterization of Clinical and Environmental Dematiaceous Fungi and Relatives From Iran, Current Medical Mycology (2021)

15. Antifungal Effect of Atorvastatin Against Candida Species in Comparison to Fluconazole and Nystatin, Medicine and Pharmacy Reports (2019)

16. Synthesis, and Molecular Docking Studies of Novel 1,2,3-Triazoles-Linked Pyrazole Carboxamides As Significant Anti-Microbial and Anti-Cancer Agents, Results in Chemistry (2024)

17. Antibacterial, Antifungal and Cytotoxic Evaluation of Some New Quinazolinone Derivatives, Research in Pharmaceutical Sciences (2012)

18. In Vitro Activities of Six Antifungal Drugs Against Candida Glabrata Isolates: An Emerging Pathogen, Jundishapur Journal of Microbiology (2016)

19. The Evaluation of the Overexpression of the Erg-11, Mdr-1, Cdr-1, and Cdr-2 Genes in Fluconazole-Resistant Candida Albicans Isolated From Ahvazian Cancer Patients With Oral Candidiasis, Journal of Clinical Laboratory Analysis (2022)

20. Antibacterial, Antifungal and Cytotoxic Evaluation of Some New 2,3-Disubstituted 4(3H)-Quinazolinone Derivatives, Research in Pharmaceutical Sciences (2012)

21. Preparation and in Vitro Evaluation of Inhalation Powder Containing Fluconazole Nanoparticles for the Treatment of Fungal Lung Infections, Journal of Isfahan Medical School (2023)

22. Investigating the Performance of Drug Delivery System of Fluconazole Made of Nano–Micro Fibers Coated on Cotton/Polyester Fabric, Journal of Materials Science: Materials in Medicine (2017)

23. Amino Acid Substitutions in Erg11p of Azole-Resistant Candida Glabrata: Possible Effective Substitutions and Homology Modelling, Journal of Global Antimicrobial Resistance (2016)

24. Antifungal Activity of Almond (Prunus Amygdalus) Hull Extracts Against Clinical Isolates of Candida Albicans, Current Medical Mycology (2024)

25. Docking Study, Synthesis and Antimicrobial Evaluation of Some Novel 4-Anilinoquinazoline Derivatives, Research in Pharmaceutical Sciences (2017)

26. The Effects of Nutraceuticals and Herbal Medicine on Candida Albicans in Oral Candidiasis: A Comprehensive Review, Advances in Experimental Medicine and Biology (2021)

27. Epidemiologic and Antifungal Susceptibility Profile of Candiduria Among Patients Hospitalized in the Nephrology and Intensive Care Unit Wards, Tehran, Iran, Jundishapur Journal of Microbiology (2022)

28. Caspofungin-Non-Susceptible Candida Orthopsilosis Isolated From Onychomycosis in Iran, Iranian Journal of Public Health (2017)

29. Design, Synthesis and Biological Activity of Hybrid Antifungals Derived From Fluconazole and Mebendazole, European Journal of Medicinal Chemistry (2023)

30. Comparison of the Antifungal Activity of Fluconazole- and Ketoconazole-Loaded Pcl/Pvp Nanofibrous Mat, Bulletin of Materials Science (2021)

31. Cerebral Phaeohyphomycosis Due to Rhinocladiella Mackenziei in Persian Gulf Region: A Case and Review, Mycoses (2018)

32. Echinophora Platyloba Dc. As a New Natural Antifungal Agent, Asian Pacific Journal of Tropical Disease (2015)

33. Candida Palmioleophila Candidemia and Bacterial Co-Infection in a 3-Month-Old Infant With Biliary Atresia, Frontiers in Cellular and Infection Microbiology (2023)

34. Multicenter Identification and Antifungal Susceptibility Patterns of Candida Species Isolated From Clinical Samples, Jundishapur Journal of Microbiology (2017)

35. Regulation of Erg3, Erg6, and Erg11 Genes in Antifungal-Resistant Isolates of Candida Parapsilosis, Iranian Biomedical Journal (2017)

36. First Fatal Cerebral Phaeohyphomycosis Due to Rhinocladiella Mackenziei in Iran, Based on Its Rdna, Journal de Mycologie Medicale (2015)

37. Otomycosis Due to the Rare Fungi Talaromyces Purpurogenus, Naganishia Albida and Filobasidium Magnum, Mycopathologia (2020)

38. Jatrophanes From Euphorbia Squamosa As Potent Inhibitors of Candida Albicans Multidrug Transporters, Journal of Natural Products (2014)

39. Evaluation of Antifungal Effect of Amphotericin B in Comparison With Nystatin on Candida Species Derived From Patients Undergoing Head‑And‑Neck Radiotherapy, Dental Research Journal (2024)

40. In Vitro Antifungal Susceptibility Pattern of Candida Species Isolated From Gastroesophageal Candidiasis, Gastroenterology and Hepatology from Bed to Bench (2021)

41. A 3-Year Study of Candida Infections Among Patients With Malignancy: Etiologic Agents and Antifungal Susceptibility Profile, Frontiers in Cellular and Infection Microbiology (2023)

42. Preparation and Pharmaceutical Evaluation of Miconazole Nitrate Mucoadhesive Films for Vaginal Candidiasis, Journal of Isfahan Medical School (2013)

43. Invasive Fungal Infections in Hematologic Malignancies: Incidence, Management, and Antifungal Therapy, Journal of Research in Medical Sciences (2023)

44. Comparative Evaluation of Ketoconazole Tablet and Topical Ketoconazole 2% in Orabase in Treatment of Candida-Infected Denture Stomatitis, Journal of Contemporary Dental Practice (2010)

45. Antifungal Activity of Zingiber Officinale Rosc. Essential Oil Against Fluconazole Resistant Vaginal Isolates of Candida Albicans, Journal of Medicinal Plants (2007)

46. Synthesis, Characterization, Molecular Docking Studies and Biological Evaluation of Some Novel Hybrids Based on Quinazolinone, Benzofuran and Imidazolium Moieties As Potential Cytotoxic and Antimicrobial Agents, Iranian Journal of Basic Medical Sciences (2017)

47. Species Distribution and Antifungal Susceptibility Profile of Candida Isolates From Blood and Other Normally Sterile Foci From Pediatric Icu Patients in Tehran, Iran, Medical Mycology (2020)

48. In Vitro Activity of Juglone (5-Hydroxy-1,4-Naphthoquinone) Against Both Fluconazole-Resistant and Susceptible Candida Isolates; [Actividad in Vitro De Juglona (5-Hidroxi-1,4-Naftoquinona) Contra Aislamientos De Candida Resistentes Y Sensibles a Fluconazol], Revista Iberoamericana de Micologia (2022)

49. Comparison of in Vitro Activities of Newer Triazoles and Classic Antifungal Agents Against Dermatophyte Species Isolated From Iranian University Hospitals: A Multi-Central Study, Annals of Clinical Microbiology and Antimicrobials (2023)

50. Antifungal Susceptibility Analysis of Clinical Isolates of Candida Parapsilosis in Iran, Iranian Journal of Public Health (2016)

Style	Citing Format
MLA	Shokoohi GR, et al.. "In Vitro Activities of Luliconazole, Lanoconazole, and Efinaconazole Compared With Those of Five Antifungal Drugs Against Melanized Fungi and Relatives." Antimicrobial Agents and Chemotherapy, vol. 61, no. 11, 2017, pp. -.
APA	Shokoohi GR, Badali H, Mirhendi H, Ansari S, Rezaeimatehkolaei A, Ahmadi B, Vaezi A, Alshahni MM, Makimura K (2017). In Vitro Activities of Luliconazole, Lanoconazole, and Efinaconazole Compared With Those of Five Antifungal Drugs Against Melanized Fungi and Relatives. Antimicrobial Agents and Chemotherapy, 61(11), -.
Chicago	Shokoohi GR, Badali H, Mirhendi H, Ansari S, Rezaeimatehkolaei A, Ahmadi B, Vaezi A, Alshahni MM, Makimura K. "In Vitro Activities of Luliconazole, Lanoconazole, and Efinaconazole Compared With Those of Five Antifungal Drugs Against Melanized Fungi and Relatives." Antimicrobial Agents and Chemotherapy 61, no. 11 (2017): -.
Harvard	Shokoohi GR et al. (2017) 'In Vitro Activities of Luliconazole, Lanoconazole, and Efinaconazole Compared With Those of Five Antifungal Drugs Against Melanized Fungi and Relatives', Antimicrobial Agents and Chemotherapy, 61(11), pp. -.
Vancouver	Shokoohi GR, Badali H, Mirhendi H, Ansari S, Rezaeimatehkolaei A, Ahmadi B, et al.. In Vitro Activities of Luliconazole, Lanoconazole, and Efinaconazole Compared With Those of Five Antifungal Drugs Against Melanized Fungi and Relatives. Antimicrobial Agents and Chemotherapy. 2017;61(11):-.
BibTex	@article{ author = {Shokoohi GR and Badali H and Mirhendi H and Ansari S and Rezaeimatehkolaei A and Ahmadi B and Vaezi A and Alshahni MM and Makimura K}, title = {In Vitro Activities of Luliconazole, Lanoconazole, and Efinaconazole Compared With Those of Five Antifungal Drugs Against Melanized Fungi and Relatives}, journal = {Antimicrobial Agents and Chemotherapy}, volume = {61}, number = {11}, pages = {-}, year = {2017} }
RIS	TY - JOUR AU - Shokoohi GR AU - Badali H AU - Mirhendi H AU - Ansari S AU - Rezaeimatehkolaei A AU - Ahmadi B AU - Vaezi A AU - Alshahni MM AU - Makimura K TI - In Vitro Activities of Luliconazole, Lanoconazole, and Efinaconazole Compared With Those of Five Antifungal Drugs Against Melanized Fungi and Relatives JO - Antimicrobial Agents and Chemotherapy VL - 61 IS - 11 SP - EP - PY - 2017 ER -